HOME >> MEDICINE >> NEWS
Patients with cancer have highly increased risk for blood clots

ation who also had cancer had a 12-fold increased risk vs. individuals without cancer and factor V Leiden. Similar results were indirectly calculated for the prothrombin 20210A mutation in patients with cancer.

"Assuming a baseline risk of 1 to 4 patients with venous thrombosis per 1,000 per year, a 5 percent prevalence of factor V Leiden and a 2 percent prevalence of the prothrombin 20210A mutation, among 10,000 patients with cancer, we would expect 8 to 34 patients with venous thrombosis due to factor V Leiden or the prothrombin 20210A mutation. Screening for factor V Leiden and the prothrombin 20210A mutation and subsequent prophylactic anticoagulant therapy with an effectivity of 80 percent would prevent annually 7 to 27 venous thrombotic events per 10,000 patients with cancer screened (numbers needed to screen: 700-2,700), which does not make screening a useful strategy. Rather than screening for factor V Leiden or the prothrombin 20210A mutation, it may be more cost-effective to consider prophylactic anticoagulant therapy for patients with cancer who have an increased risk to develop venous thrombosis," the authors conclude.
(JAMA. 2005;293:715-722. Available post-embargo at JAMA.com)

Editor's Note: This research was supported by grants from the Netherlands Heart Foundation and from the Dutch Cancer Foundation.


'"/>

Contact: Frits R. Rosendaal, M.D., Ph.D.
f.r.rosendaal@lumc.nl
JAMA and Archives Journals
8-Feb-2005


Page: 1 2

Related medicine news :

1. Patients newly diagnosed with HIV are more likely to enter outpatient care with case management
2. Patients with previous heart attacks may not benefit from pacemaker implant
3. Patients with cancer detected on screening mammography undergo less toxic treatment
4. Patients with moderate or severe hand dermatitis responsive to drug therapy
5. Patients with abdominal trauma at risk for intra-abdominal infections following surgery
6. Patients who are intubated prior to hospital arrival fare worse find Pitt researchers
7. Patients undergoing weight loss surgery have high rates of H pylori bacteria
8. Patients with chronic sinus do not necessarily develop antibiotic resistance
9. Plastic surgeons honor Patients of Courage overcoming difficult obstacles, inspiring others
10. Patients with severe depression improve using guidelines developed by UT Southwestern researchers
11. Patients not sticking to cholesterol drugs -- and the higher their co-pay, the lower their use

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Patients with cancer have highly increased risk for blood clots

(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... be at increased risk of suffering depression after giving ... hope they can use the findings to develop a ... are vulnerable to postpartum depression, which affects around 15 ... the May 21 issue of the journal Molecular ...
(Date:5/21/2013)... 2013 Pathways Home Health, Hospice ... to remember and honor a loved one in the ... Service, Sunday, June 2, 2013, 3-4 pm at Skylawn ... Mateo, CA 94402. , The Pathways Hospice Evening of ... program with music, readings and support. Open to the ...
(Date:5/21/2013)... patients are significantly more likely than their normal-weight ... practice that disrupts continuity of care and leads ... research suggests. , The practice of "doctor shopping" ... negative experiences with the health care system, whether ... weight loss advice by providers, or improperly sized ...
(Date:5/21/2013)... 2013 STAR (Sensory Therapies And ... with sensory challenges and the Sensory Processing Disorder ... and advocacy of Sensory Processing Disorder present Stumbling Blocks ... Improve Quality of Life, a two-hour lecture presented by ... , Learn a method that can aid in ...
(Date:5/21/2013)... Diehard soccer fans will definitely want to ... the game between Manchester City and Chelsea FC ... These two teams are highly decorated in the English Premiere ... to the Busch Stadium, home of the St. Louis Cardinals, ... time that a professional sporting event and non-baseball game will ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Hospice Offers Evening of Remembrance Memorial Service in San Mateo, California 2Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3Health News:Manchester City vs. Chelsea FC Tickets: Cheap Concert Tickets has Slashed Prices on Manchester City vs. Chelsea FC Tickets at Busch Stadium in St. Louis, MO 2
(Date:5/21/2013)... UNION CITY, Calif. , May 21, 2013 /PRNewswire/ ... manufacturing point-of-care blood analysis systems, announced today that ... will present at the Stifel Annual Dental & Veterinary ... ET. The conference will be held at Le Parker ... . About Abaxis Abaxis develops, ...
(Date:5/21/2013)...  BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC ... stem cell based therapies for various personal applications, announced ... and CEO, will be presenting at the Marcum MicroCap ... on Thursday, May 30, 2013 at the Grand Hyatt ... York City.  Mr. Weinreb,s presentation will take place at ...
(Date:5/21/2013)... SAN DIEGO , May 21, 2013 /PRNewswire/ ... from a secondary analysis of its double-blind, randomized, ... CERE-120 is a gene therapy product designed to ... This exploratory analysis identified a more robust response ... years prior to treatment relative to those diagnosed ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
Cached News: